DSpace

DSpace at RU >

Search Results

 
for  

Results 1-18 of 18.

Sort items by In order  |  Results/Page Authors/record

Item hits:

Full TextIssue DateTitleAuthor(s)
2011Labor dystocia as First presentation of pelvic malignancy.Hamont, D. van; Zusterzeel, P.L.M.
2011Robot-assisted versus total laparoscopic radical hysterectomy in early cervical cancer, a reviewKruijdenberg, C.B.; Einden, L.C.G. van den; Hendriks, J.C.M.; Zusterzeel, P.L.M.; Bekkers, R.L.M.
2011Cytokine analysis as a tool to understand tumour-host interaction in ovarian cancerYigit, R.; Figdor, C.G.; Zusterzeel, P.L.M.; Pots, J.M.; Torensma, R.; Massuger, L.F.A.G.
2011External validation of the adapted Risk of Malignancy Index incorporating tumor size in the preoperative evaluation of adnexal masses.Akker, P.A. van den; Zusterzeel, P.L.M.; Aalders, A.L.; Snijders, M.P.; Samlal, R.A.; Vollebergh, J.H.A.; Kluivers, K.B.; Massuger, L.F.A.G.
2011Factors influencing the use of frozen section analysis in adnexal massesvan den Akker, P.A.; Kluivers, K.B.; Aalders, A.L.; Snijders, M.P.; Samlal, R.A.; Vollebergh, J.H.A.; Zusterzeel, P.L.M.; Massuger, L.F.A.G.
2011Cytokine profiles in cyst fluids from ovarian tumors reflect immunosuppressive state of the tumorYigit, R.; Massuger, L.F.A.G.; Zusterzeel, P.L.M.; Pots, J.M.; Figdor, C.G.; Torensma, R.
2009Serum vascular endothelial growth factor: a prognostic factor in cervical cancer.Zusterzeel, P.L.M.; Span, P.N.; Dijksterhuis, M.G.; Thomas, C.M.G.; Sweep, F.C.; Massuger, L.F.A.G.
2009GSTP1-1 in ovarian cyst fluid and disease outcome of patients with ovarian cancer.Kolwijck, E.; Zusterzeel, P.L.M.; Roelofs, H.M.J.; Hendriks, J.C.M.; Peters, W.H.M.; Massuger, L.F.A.G.
2008Prognostic factors for recurrence in patients with FIGO stage I and II, intermediate or high risk endometrial cancer.Zusterzeel, P.L.M.; Bekkers, R.L.M.; Hendriks, J.C.M.; Neesham, D.N.; Rome, R.M.; Quinn, M.A.
2007Susceptibility to pre-eclampsia is associated with multiple genetic polymorphisms in maternal biotransformation enzymes.Zusterzeel, P.L.M.; Peters, W.H.M.; Burton, G.J.; Visser, W. de; Roelofs, H.M.J.; Steegers, E.A.P.
2006Susceptibility to Pre-Eclampsia Is Associated with Multiple Genetic Polymorphisms in Maternal Biotransformation Enzymes.Zusterzeel, P.L.M.; Peters, W.H.M.; Burton, G.J.; Visser, W.A.; Roelofs, H.M.J.; Steegers, E.A.P.
2006Oral N-acetylcysteine administration does not stabilise the process of established severe preeclampsia.Roes, E.M.; Raijmakers, M.; Boo, T.M. de; Zusterzeel, P.L.M.; Merkus, H.M.; Peters, W.H.M.; Steegers, E.A.P.
2005N-acetyl-transferase phenotype and risk for preeclampsia.Zusterzeel, P.L.M.; Morsche, R.H.M. te; Raijmakers, M.; Roes, E.M.; Peters, W.H.M.; Steegers-Theunissen, R.P.M.; Steegers, E.A.P.
2004First trimester inhibin-A concentrations and later development of preeclampsia.Roes, E.M.; Gaytant, M.A.; Thomas, C.M.G.; Raijmakers, M.; Zusterzeel, P.L.M.; Peters, W.H.M.; Steegers, E.A.P.
2004Shift in expression of HLA-G mRNA spliceforms in pregnancies complicated by preeclampsia.Emmer, P.M.; Joosten, I.; Schut, M.H.; Zusterzeel, P.L.M.; Hendriks, J.C.M.; Steegers, E.A.P.
2004Thiol status and antioxidant capacity in women with a history of severe pre-eclampsiaRaijmakers, M.; Roes, E.M.; Zusterzeel, P.L.M.; Steegers, E.A.P.; Peters, W.H.M.
2002Ethene and other biomarkers of oxidative stress in hypertensive disorders of pregnancy.Zusterzeel, P.L.M.; Steegers-Theunissen, R.P.M.; Harren, F.J.M.; Stekkinger, E.; Kateman, H.; Timmerman, B.H.; Berkelmans, R.; Nieuwenhuizen, A.; Peters, W.H.M.; Raijmakers, M.; Steegers, E.A.P.
1997Selective follicular reduction: what to do with the oocytes?Zusterzeel, P.L.M.; Kremer, J.A.M.; Duijkers, I.J.M.; Coenen, C.M.H.

1

 

  DSpace Software Copyright © 2002-2011  Duraspace - Feedback